ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents
暂无分享,去创建一个
Amandine Rovini | Diane Braguer | M. Carré | A. Rovini | D. Braguer | V. Bourgarel-Rey | Veronique Bourgarel-Rey | Marion Le Grand | Stephane Honore | Sonia Bastonero | Manon Carre | Marie Le Grand | S. Bastonero | S. Honoré | M. L. Grand
[1] V. Torchilin,et al. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[2] Gergő Bohner,et al. EBs Recognize a Nucleotide-Dependent Structural Cap at Growing Microtubule Ends , 2012, Cell.
[3] James W. Smyth,et al. Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. , 2010, The Journal of clinical investigation.
[4] P. Lollini,et al. NVP-BEZ235 as a New Therapeutic Option for Sarcomas , 2010, Clinical Cancer Research.
[5] A. Savry,et al. Microtubule-targeted agents: when mitochondria become essential to chemotherapy. , 2011, Biochimica et biophysica acta.
[6] V. Weissig. Mitochondria-specific nanocarriers for improving the proapoptotic activity of small molecules. , 2012, Methods in enzymology.
[7] G. Borisy,et al. Migration and actin protrusion in melanoma cells are regulated by EB1 protein. , 2009, Cancer letters.
[8] Hui Sun,et al. Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition. , 2011, Cancer letters.
[9] R. Berges,et al. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends. , 2012, Biochemical pharmacology.
[10] F. Huang,et al. VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions. , 2012, Molecular cell.
[11] M. Carré,et al. Microtubules in apoptosis induction: are they necessary? , 2007, Current cancer drug targets.
[12] Xia Ding,et al. EB1 acetylation by P300/CBP-associated factor (PCAF) ensures accurate kinetochore–microtubule interactions in mitosis , 2012, Proceedings of the National Academy of Sciences.
[13] Tomohiro Matsumoto,et al. A mutation of the fission yeast EB1 overcomes negative regulation by phosphorylation and stabilizes microtubules. , 2012, Experimental cell research.
[14] P. Rustin,et al. Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells. , 2012, Biochemical and biophysical research communications.
[15] S. Étienne-Manneville. APC in cell migration. , 2009, Advances in experimental medicine and biology.
[16] A. Kruczynski,et al. Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status , 2013, PloS one.
[17] C. Jiang,et al. 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway , 2014, Anti-cancer drugs.
[18] Viji M. Draviam,et al. Microtubule plus-ends within a mitotic cell are ‘moving platforms’ with anchoring, signalling and force-coupling roles , 2012, Open Biology.
[19] Sonia Grego,et al. EB1-microtubule interactions in Xenopus egg extracts: role of EB1 in microtubule stabilization and mechanisms of targeting to microtubules. , 2002, Molecular biology of the cell.
[20] J. Franklin. Redox regulation of the intrinsic pathway in neuronal apoptosis. , 2011, Antioxidants & redox signaling.
[21] Jorge G. Ferreira,et al. Aurora B spatially regulates EB3 phosphorylation to coordinate daughter cell adhesion with cytokinesis , 2013, The Journal of cell biology.
[22] D. Green,et al. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. , 2006, Molecular cell.
[23] M. Carré,et al. Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. , 2010, Biochemical pharmacology.
[24] R. Moreno-Sánchez,et al. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. , 2010, Molecular aspects of medicine.
[25] Gary G. Borisy,et al. Mammalian end binding proteins control persistent microtubule growth , 2009, The Journal of cell biology.
[26] C. Cubitt,et al. MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines , 2013, Cancer biology & therapy.
[27] K. E. Busch,et al. The Microtubule Plus End-Tracking Proteins mal3p and tip1p Cooperate for Cell-End Targeting of Interphase Microtubules , 2004, Current Biology.
[28] J. McCubrey,et al. Cancer esearch apeutics , Targets , and Chemical Biology ivity of the Novel Dual Phosphatidylinositol 3-Kinase / malian Target of Rapamycin Inhibitor NVP-BEZ 235 R inst T-Cell Acute Lymphoblastic Leukemia , 2010 .
[29] D. Trisciuoglio,et al. Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used. , 2002, European journal of cancer.
[30] Kai Jiang,et al. Microtubule tip-interacting proteins: a view from both ends. , 2011, Current opinion in cell biology.
[31] A. Hyman,et al. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation , 2001, Current Biology.
[32] F. Gallyas,et al. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. , 2001, Free radical biology & medicine.
[33] B. Stiles. PI-3-K and AKT: Onto the mitochondria. , 2009, Advanced drug delivery reviews.
[34] Nan Li,et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. , 2013, Biomaterials.
[35] K. Kaibuchi,et al. AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation , 2010, Nature Cell Biology.
[36] J. Satayavivad,et al. Glycogen synthase kinase-3 (GSK3) controls deoxyglucose-induced mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells. , 2014, Mitochondrion.
[37] Anna Akhmanova,et al. Tracking the ends: a dynamic protein network controls the fate of microtubule tips , 2008, Nature Reviews Molecular Cell Biology.
[38] H. Kovacic,et al. Patupilone-Induced Apoptosis Is Mediated by Mitochondrial Reactive Oxygen Species through Bim Relocalization to Mitochondria , 2008, Molecular Pharmacology.
[39] A. Kruczynski,et al. Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites , 2008, Molecular Cancer Therapeutics.
[40] R. Rossignol,et al. Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies. , 2013, The international journal of biochemistry & cell biology.
[41] D. Xing,et al. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission–fusion proteins , 2011, The FEBS journal.
[42] N. Chandel,et al. Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.
[43] C. Dumontet,et al. Microtubule-binding agents: a dynamic field of cancer therapeutics , 2010, Nature Reviews Drug Discovery.
[44] E. Pasquier,et al. Understanding microtubule dynamics for improved cancer therapy , 2005, Cellular and Molecular Life Sciences CMLS.
[45] V. Gogvadze. Targeting mitochondria in fighting cancer. , 2011, Current pharmaceutical design.
[46] G. Dulan,et al. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. , 2011, American journal of physiology. Cell physiology.
[47] Ø. Bruserud,et al. Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling , 2007, Expert opinion on therapeutic targets.
[48] Min Liu,et al. Microtubule‐binding protein CLIP‐170 is a mediator of paclitaxel sensitivity , 2012, The Journal of pathology.
[49] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[50] R. Rossignol,et al. AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation. , 2011, Biochimica et biophysica acta.
[51] N. Holbrook,et al. Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.
[52] E. Morrison,et al. EB1 Is Required for Spindle Symmetry in Mammalian Mitosis , 2011, PloS one.
[53] Xiaobo Zhou,et al. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating β-catenin/TCF pathway , 2005, Oncogene.
[54] W. Alexander,et al. Inhibiting the akt pathway in cancer treatment: three leading candidates. , 2011, P & T : a peer-reviewed journal for formulary management.
[55] K. Mechtler,et al. Phosphoregulation of the budding yeast EB1 homologue Bim1p by Aurora/Ipl1p , 2009, The Journal of cell biology.
[56] Sam-Yong Park,et al. Mitotic Regulation of the Stability of Microtubule Plus-end Tracking Protein EB3 by Ubiquitin Ligase SIAH-1 and Aurora Mitotic Kinases* , 2009, The Journal of Biological Chemistry.
[57] K. Stroka,et al. Physical confinement alters tumor cell adhesion and migration phenotypes , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] Li Fu,et al. Oncogenic function of microtubule end‐binding protein 1 in breast cancer , 2010, The Journal of pathology.
[59] A. Kruczynski,et al. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine , 2006, Molecular Cancer Therapeutics.
[60] Gergő Bohner,et al. EB1 Accelerates Two Conformational Transitions Important for Microtubule Maturation and Dynamics , 2014, Current Biology.
[61] T. Laessig,et al. Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis , 2004, The Journal of Neuroscience.
[62] E. Pasquier,et al. Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. , 2004, Molecular cancer therapeutics.
[63] D. Braguer,et al. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'. , 2000, Cancer research.
[64] V. Sondak,et al. Inhibition of autophagy enhances the effects of the AKT inhibitor MK‐2206 when combined with paclitaxel and carboplatin in BRAF wild‐type melanoma , 2014, Pigment cell & melanoma research.
[65] J. Eisenbart,et al. Mitochondrial complex III ROS regulate adipocyte differentiation. , 2011, Cell metabolism.
[66] I. Smal,et al. End-binding proteins sensitize microtubules to the action of microtubule-targeting agents , 2013, Proceedings of the National Academy of Sciences of the United States of America.
[67] A. Savry,et al. Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment. , 2013, Neoplasia.